Protocol Ledger

NCT03297606 · Phase II · RECRUITING

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

Interventional Phase II clinical trial protocol NCT03297606 sponsored by Canadian Cancer Trials Group in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-03-23 Enrollment: 720 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03297606
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)720 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03297606
Protocol FieldVerified Registry Value
NCT IdentifierNCT03297606
Consolidated Lead SponsorCanadian Cancer Trials Group
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment720 participants (ESTIMATED)
Registered Start Date2018-03-23
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03297606
Hospital Research SiteLocationSite Profile
Cross Cancer InstituteEdmonton, CanadaOpen Hospital Dossier ->
University Health NetworkToronto, CanadaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI